<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:department>Faculty of Engineering &amp; the Environment</gtr:department><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4C306043-3DCB-4521-86C1-77D580E4AA30"><gtr:id>4C306043-3DCB-4521-86C1-77D580E4AA30</gtr:id><gtr:firstName>Xunli</gtr:firstName><gtr:surname>Zhang</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FG009732%2F1"><gtr:id>7123DE28-4AB0-43BB-9E8A-672612180A72</gtr:id><gtr:title>Integrated Synthesis and Characterisation of Organic Nanoparticles Using Microfluidic Technology for Drug Delivery Applications</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/G009732/1</gtr:grantReference><gtr:abstractText>Over the last decade, nanomedicine has emerged as a new field of medicine where nanoscale materials has been used to deliver a wide range of pharmaceutically active organic compounds such as drugs, genes, and imaging agents. There remain challenges, however, to synthesise and formulate organic compound based nanostructured materials, although the synthesis of inorganic nanomaterials has indeed been extensively studied over decades with good control of particle shape and size. Consequently, special formulation techniques are required to disperse the solid organic materials into water, maintain the dispersion for a certain time period, and functionalise the organic nanoparticles. Using selected experimental systems, we propose taking a radically new fast approach for making nanoscale particles and formulating them, which will not only do away with the grinding process but will also lead to a better understanding of the basic science behind product formulation allowing us to develop new improved products. The proposed method is based on the so-called Lab-on-a-Chip concept which represents the potential to shrink conventional bench chemical systems to the size of a few centimeters square. The main feature of such micro systems is the micron scale channel network with a channel width of about 100 micrometers (about the diameter of a human hair), where chemicals are brought together, using a variety of pumping techniques, for synthesis, separation or analysis. Relevant to the formulation of organic nanoparticles, the advantages of microfluidic and Lab-on-a-Chip technology will enable us to not only make particles of a very well controlled size distribution, but also integrate a number of measurement systems into the microreactor in order to monitor the process when the particles are generated, and more importantly, to institute real time feedback. It is envisaged this development will, for the first time, let us understand more about what is important in formulation science and how we can develop new strategies for new and better products in the future.</gtr:abstractText><gtr:fund><gtr:end>2012-09-26</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2009-03-27</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>302167</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Biocompatibles</gtr:department><gtr:description>Biocompatibles Ltd</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>BTG</gtr:fundingOrg><gtr:fundingRef>10962/01</gtr:fundingRef><gtr:id>E68A7624-788F-406B-891C-A6C4B773AF92</gtr:id><gtr:outcomeId>r-1603799920.160137206a6f540</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Biocompatibles</gtr:department><gtr:description>Biocompatibles Ltd</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>BTG</gtr:fundingOrg><gtr:fundingRef>10962/01</gtr:fundingRef><gtr:id>5B111DFC-29CE-49A1-A688-BEF13C2BAB66</gtr:id><gtr:outcomeId>5ed34c505ed34c64</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Impact generated from the Award include:
i). Initial implementation of microfluidic technologies/systems by a medical device manufacturers for evaluating embolic devices, and by a pharmaceutical company for continuous flow synthesis of pharmaceutical intermediates; 
ii). Developing extensive expertise in microfluidics, and training personnel in a rapidly expanding area with a shortage of people, resulting in 2 PhDs winning the Best Medical Engineering PhD Thesis 2013, and the UK Life Sciences Skills Award for Postgraduate of the Year 2012.</gtr:description><gtr:firstYearOfImpact>2010</gtr:firstYearOfImpact><gtr:id>48E78A89-1235-4CF2-A11E-B26E7DE27DDA</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56c5b069608c67.87727600</gtr:outcomeId><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>(i). Optimised processes for design and fabrication of microfluidic devices; 
(ii). Quantitative characterisation and modelling of microfluidic dynamics; 
(iii). Controlled synthesis of nano- and micro- structured drug delivery systems;
(iv). Evaluation of nano- and micro- structured drug delivery systems.</gtr:description><gtr:exploitationPathways>Key scientific findings and development from the Award have paved ways for the development of further proposals related to nanomedicine synthesis and drug delivery. The technology platform has also been employed by industrial partners to assist their product design and evaluation.</gtr:exploitationPathways><gtr:id>A2E01B13-D5C0-495D-886C-60E412208C3C</gtr:id><gtr:outcomeId>56c5af69a5d4d8.45134110</gtr:outcomeId><gtr:sectors><gtr:sector>Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.southampton.ac.uk/engineering/about/staff/xz1f06.page#publications</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The development of microfluidic devices and methods has been used for for in vitro testing of therapeutic biofluidic-related procedures such as blood flow, chemoembolisation. and stended ureteric flow.</gtr:description><gtr:id>FE0CFE08-719E-42BE-87C0-03E53D61BABD</gtr:id><gtr:impact>This research tool and method have been provided to an industrial collaborator for evaluating their products.</gtr:impact><gtr:outcomeId>56d44f8ba8fcf7.86514518</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Microfluidic devices and methods for in vitro testing of therapeutic biofluidic-related procedures</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9C734D1A-9BE3-46ED-97A6-BEEAB0B3DFE0</gtr:id><gtr:title>microspectroscopic monitoring within a microfluidic reactor</gtr:title><gtr:parentPublicationTitle>RSC Adv.</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b617d529e92d0a2e8cd98aff2501b9ec"><gtr:id>b617d529e92d0a2e8cd98aff2501b9ec</gtr:id><gtr:otherNames>Zmijan R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5675fcdc22532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A22D9E4-09BF-4EB1-8A05-5CE1F1BC7D23</gtr:id><gtr:title>Microfluidic reactors for controlled synthesis of polymeric micelles.</gtr:title><gtr:parentPublicationTitle>Journal of controlled release : official journal of the Controlled Release Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3172390f51bb0d51d0949b8f1b8330a2"><gtr:id>3172390f51bb0d51d0949b8f1b8330a2</gtr:id><gtr:otherNames>Capretto L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0168-3659</gtr:issn><gtr:outcomeId>doi_53cff8ff8fc89962</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67060014-850E-4F94-91FB-82E6943D2555</gtr:id><gtr:title>Micromixing within microfluidic devices.</gtr:title><gtr:parentPublicationTitle>Topics in current chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3172390f51bb0d51d0949b8f1b8330a2"><gtr:id>3172390f51bb0d51d0949b8f1b8330a2</gtr:id><gtr:otherNames>Capretto L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:isbn>978-3-642-23049-3</gtr:isbn><gtr:issn>0340-1022</gtr:issn><gtr:outcomeId>doi_53cfcbfcb41dae27</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3956AE0E-777F-4F90-AE48-3FB05B17BB75</gtr:id><gtr:title>Mechanism of co-nanoprecipitation of organic actives and block copolymers in a microfluidic environment.</gtr:title><gtr:parentPublicationTitle>Nanotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3172390f51bb0d51d0949b8f1b8330a2"><gtr:id>3172390f51bb0d51d0949b8f1b8330a2</gtr:id><gtr:otherNames>Capretto L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0957-4484</gtr:issn><gtr:outcomeId>doi_53d042042a28239f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>252AC61C-ABB3-4D17-96A7-16ADCDD67988</gtr:id><gtr:title>Continuous-flow production of polymeric micelles in microreactors: experimental and computational analysis.</gtr:title><gtr:parentPublicationTitle>Journal of colloid and interface science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3172390f51bb0d51d0949b8f1b8330a2"><gtr:id>3172390f51bb0d51d0949b8f1b8330a2</gtr:id><gtr:otherNames>Capretto L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9797</gtr:issn><gtr:outcomeId>doi_53cff8ff8df572ff</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>412D63E4-54C1-429A-85BF-0960DBB50FD7</gtr:id><gtr:title>Mithramycin encapsulated in polymeric micelles by microfluidic technology as novel therapeutic protocol for beta-thalassemia.</gtr:title><gtr:parentPublicationTitle>International journal of nanomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3172390f51bb0d51d0949b8f1b8330a2"><gtr:id>3172390f51bb0d51d0949b8f1b8330a2</gtr:id><gtr:otherNames>Capretto L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1176-9114</gtr:issn><gtr:outcomeId>56c4a5f83b5038.31737449</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3AACE62F-9955-4ACA-8323-256CF216EC03</gtr:id><gtr:title>Microfluidic and lab-on-a-chip preparation routes for organic nanoparticles and vesicular systems for nanomedicine applications.</gtr:title><gtr:parentPublicationTitle>Advanced drug delivery reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3172390f51bb0d51d0949b8f1b8330a2"><gtr:id>3172390f51bb0d51d0949b8f1b8330a2</gtr:id><gtr:otherNames>Capretto L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0169-409X</gtr:issn><gtr:outcomeId>56c4a5f8ba0150.71610628</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA66DBD2-6EE9-48B1-9AF3-722914EAC5B1</gtr:id><gtr:title>Production of polymeric micelles by microfluidic technology for combined drug delivery: application to osteogenic differentiation of human periodontal ligament mesenchymal stem cells (hPDLSCs).</gtr:title><gtr:parentPublicationTitle>International journal of pharmaceutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3172390f51bb0d51d0949b8f1b8330a2"><gtr:id>3172390f51bb0d51d0949b8f1b8330a2</gtr:id><gtr:otherNames>Capretto L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0378-5173</gtr:issn><gtr:outcomeId>56c4a5f894a965.52476860</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/G009732/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>99E0B904-CAB5-4511-AFB3-AA6D2B171F97</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Process engineering</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>04DC091E-A791-4572-A9B7-E327BB0A3EB8</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Particle Technology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>B502FBF6-8A62-4845-B561-BAB94EAA09E9</gtr:id><gtr:percentage>80</gtr:percentage><gtr:text>Reactor Engineering</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>